FindTrial
Sign In

Evaluation of annotations for cancer gene panel testing using a genome-guided system

Evaluation of annotations for cancer gene panel testing using a genome-guided system - Evaluation of annotations for cancer gene panel testing using a genome-guided system

Status
Recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000043282
Enrollment
10
Registered
2021-02-08
Start date
2021-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer patients who have undergone cancer gene panel testing at the St. Marianna University, School of Medicine Hospital Center for Genomic Medicine, and given consent to secondary use of the test results when they took the public insurance-covered cancer gene panel testing.

Interventions

None listed

Sponsors

St. Marianna University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who underwent cancer gene panel testing at the Center for Genomic Medicine, St. Marianna University School of Medicine Hospital 2. Patients who consented to the secondary use of panel test data conducted by the University in the consent form used for the insurance-covered cancer genetic panel tests

Exclusion criteria

Exclusion criteria: Cases in which the principal researcher determines that participation in this study is inappropriate

Design outcomes

Primary

MeasureTime frame
Annotation success rate—

Countries

Japan

Contacts

Public ContactYu Sunakawa

St. Marianna University School of Medicine Hospital Center for Genomic Medicine

y.sunakawa@marianna-u.ac.jp044-977-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026